3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
31
Other
5
NET
4
Endocrine
4
Thoracic
3
Head & Neck
3
Sarcoma
2
Genitourinary
2
CNS
2
Other neoplasm
1
Lymphoid
1
Gynecologic
1
Dermatologic
1
Breast
1
Conditions
Brain Neoplasms
1905
Glioblastoma
1797
Glioma
1130
Central Nervous System Neoplasms
599
Astrocytoma
594
Neuroblastoma
552
Gliosarcoma
465
Oligodendroglioma
364
Neoplasms
312
Breast Neoplasms
273
Medulloblastoma
272
Carcinoma, Non-Small-Cell Lung
227
Recurrence
199
Sarcoma
184
Neoplasm Metastasis
183
Melanoma
182
Meningioma
177
Ependymoma
176
Lung Neoplasms
157
Lymphoma
134
Osteosarcoma
127
Meningeal Carcinomatosis
126
Neurofibromatosis 1
114
Wilms Tumor
111
Ovarian Neoplasms
110
Diffuse Intrinsic Pontine Glioma
105
Precursor Cell Lymphoblastic Leukemia-Lymphoma
103
Rhabdomyosarcoma
101
Lymphoma, Non-Hodgkin
96
Burkitt Lymphoma
89
Interventions
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Intestinal Diseases
×
CNS
×
Clear all
NCT04755920
2024-05-09
SGM-CBM
Leiden University Medical Center
Phase 2
Unknown
10 enrolled
NCT04644315
2023-08-07
ALpha-T
Hoffmann-La Roche
Phase 2
Terminated
1 enrolled
5 charts